Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

BVL/LLYUS stock hub

BVL/LLYUS has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

BVL/LLYUSis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

2.9T

Lima Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

BVL/LLYUS

In the news

Latest news · BVL/LLYUS

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E25.4

P25 n/aP50 n/aP75 n/a

Trailing P/E33

P25 n/aP50 n/aP75 n/a

ROE107.5

P25 n/aP50 n/aP75 n/a

ROIC41.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All BVL/LLYUS market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

206

Groups with data

Currency

USD

Showing 206 of 206 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	PE
Employees	50,000
Employees Change	3,000%
Employees Change Percent	6.38
Enterprise value	$3T
Exchange	Lima Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	$2.9T
Price	$868
Price currency	USD
Rev Per Employee	5,044,280.68x
Sic	2834
Symbol	bvl/LLYUS
Website	https://www.lilly.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	3.03%
EV Earnings	34.47x
EV/EBIT	25.85x
EV/EBITDA	24.25x
EV/FCF	73.7x
EV/Sales	12.23x
FCF yield	1.42%
Forward P/E	25.41x
P/B ratio	26.74x
P/E ratio	33x
P/S ratio	11.55x
PE Ratio10 Y	52.61x
PE Ratio3 Y	73.78x
PE Ratio5 Y	62.71x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	47.3%
EBITDA Margin	50.13%
FCF margin	16.36%
Gross margin	82.83%
Gross Profit	$208.9B
Gross Profit Growth	49.48%
Gross Profit Growth Q	54.44%
Gross Profit Growth3 Y	40.65%
Gross Profit Growth5 Y	25.35%
Net Income	$88.2B
Net Income Growth	127.6%
Net Income Growth Q	168.07%
Net Income Growth3 Y	64.42%
Net Income Growth5 Y	32.92%
Pretax Margin	43.08%
Profit Margin	34.99%
Profit Per Employee	$1.8M
ROA	20.74
Roa5y	13.51
ROCE	42.75
ROE	107.5
Roe5y	74.21
ROIC	41.92
Roic5y	35.51

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	0.46%
EPS Growth	129.1
EPS Growth Q	169.9
EPS Growth3 Y	64.8
EPS Growth5 Y	33.34
FCF Growth	216.44%
FCF Growth Q	1,827.56%
FCF Growth3 Y	36.63%
FCF Growth5 Y	13.11%
OCF Growth	119.79%
OCF Growth Q	220.11%
OCF Growth10 Y	21.88%
OCF Growth3 Y	44.46%
OCF Growth5 Y	21.25%
Revenue Growth	47.44x
Revenue Growth Q	55.54x
Revenue Growth3 Y	37.67x
Revenue Growth5 Y	23.17x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.7
Assets	$407B
Cash	$18.4B
Current Assets	$188.9B
Current Liabilities	$126.2B
Debt	$151.4B
Debt EBITDA	$1.19
Debt Equity	$1.39
Debt FCF	$3.67
Equity	$108.9B
Interest Coverage	388.3
Liabilities	$298B
Long Term Assets	$218B
Long Term Liabilities	$171.8B
Net Cash	$-131.4B
Net Cash By Market Cap	$-4.51
Net Debt EBITDA	$1.04
Net Debt Equity	$1.21
Net Debt FCF	$3.18
Tangible Book Value	$61.8B
Tangible Book Value Per Share	$69.13

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.5
Inventory Turnover	1.04
Net Working Capital	$59.1B
Quick ratio	0.72
Working Capital	$63.5B
Working Capital Turnover	$17.16

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.57%
Dividend Growth	7.79%
Dividend Growth Years	2%
Dividend per share	$21.75
Dividend Years	3
Dividend Yield	2.51%
Ex Div Date	2026-02-13
Last Dividend	$5.8
Payout Frequency	Quarterly
Payout Ratio	22.1%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	0.46%
200-day SMA	916.1
50-day SMA	954
50-day SMA vs 200-day SMA	50over200
All Time High	1,096
All Time High Change	-20.78%
All Time High Date	2026-02-04
All Time Low	632.7
All Time Low Change	37.23%
All Time Low Date	2025-08-08
ATR	16.08
Ch YTD	-13.78
High52	1,096
High52 Date	2026-03-02
High52ch	-20.78%
Low52	632.7
Low52 Date	2025-08-08
Low52ch	37.23%
Ma50ch	-8.98%
Price vs 200-day SMA	-5.22%
RSI	39.91
RSI Monthly	48.21
RSI Weekly	35.84
Sharpe ratio	0.14x
Sortino ratio	0.31
Total Return	3.08%
Tr YTD	-13.64
Tr1m	-6.59%
Tr1w	-9.52%
Tr3m	-20.65%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$119.3B
Operating Income Growth	74.29
Operating Income Growth Q	84.42
Operating Income Growth3 Y	64.3
Operating Income Growth5 Y	36.9
Operating margin	47.3

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	889,347,313%
Net Borrowing	15,381,828,000
Shares Insiders	0.17%
Shares Institutions	90.01%
Shares Qo Q	-0.23%
Shares Yo Y	-0.57%
Short Ratio	2.62

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$39.1B
Average Volume	7.45x
Bv Per Share	121.9
CAPEX	$-30.2B
Ch1m	-6.59
Ch1w	-9.52
Ch1y	-0.26
Ch3m	-20.78
Ch6m	-5.42
Change	0%
Close	868.3
Depreciation Amortization	7,039,667,250
Earnings Date	2026-04-30
EBIT	$119.3B
EBITDA	$126.4B
EPS	$98.27
F Score	6
FCF	$41.3B
FCF EV Yield	1.36x
Financing CF	-24,656,226,700
Fiscal Year End	December
Founded	1,876
Goodwill	21,122,447,500
Graham Number	138.64576
Graham Upside	-84.03
Income Tax	$20.4B
Investing CF	-40,267,531,500
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Lynch Fair Value	$658
Lynch Upside	-24.25
Ma150	977.2
Ma150ch	-11.15%
Ma20	898.9
Ma20ch	-3.41%
Net CF	7,641,580,100
P FCF Ratio	70.56
P OCF Ratio	40.73
Payment Date	2026-03-10
Ppne	91,450,205,000
Price Date	2026-05-08
Price EBITDA	$23.03
Ptbv Ratio	47.15
Relative Volume	4.23x
Revenue	252,214,034,100x
SBC By Revenue	0.88x
Share Based Comp	2,209,739,700
Tax By Revenue	8.09x
Tax Rate	18.79%
Tr6m	-5.13%
Z Score	7.62

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

BVL/LLYUS dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+2.5%

$21.8 annual per share

Payout ratio

+22.1%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

2 consecutive years of growth

Total shareholder yield

+3.1%

Next ex-dividend date: 2026-02-13

Performance

BVL/LLYUS stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns BVL/LLYUS?

Insider, institutional, and short-interest positioning.

Institutional ownership

+90.0%

Share of float held by funds and institutions

Insider ownership

+0.2%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

BVL/LLYUS momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

39.9

Neutral momentum band

Price vs 200-day MA

-5.2%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.14

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About BVL/LLYUS

Hub-level FAQ points readers to the deeper analysis pages.

What is the current bvl/LLYUS stock rating?

bvl/LLYUS is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full bvl/LLYUS analysis?

The full report lives at /stocks/bvl/LLYUS/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for bvl/LLYUS?

The latest report frames bvl/LLYUS around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the bvl/LLYUS page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.